Bone marrow derived dendritic cells (BMDCs) and bone marrow derived macrophages (BMDMs) were differentiated from bone marrow cells, obtained from the mice detailed above, as previously described [29 (link)]. In brief, cells were grown in complete RPMI 1640 with GlutaMAX (Gibco) with 10% FCS (Biowest), 1mM sodium pyruvate, HEPES 10mM, MEM non-essential amino acids, 2Mercaptoethanol 0,05mM and gentamicin 0,02mg/ml (all from Gibco). BMDCS and BMDMs were differentiated with GM-CSF from J558L cell line supernatants [30 (link)] or M-CSF from L929 fibroblast cell line supernatants, respectively. At day 8 and 7, respectively, BMDCs were 80% CD11c+CD11b+ and BMDMs were 95% CD11c-CD11b+. Total cells were harvested and cultured in 6-well plates (3x106/well) and stimulated for 6 h with killed or live L. major promastigotes at a parasite/cell ratio of 5:1, or 250 ng/ml of CpG 1826 or 100ng/ml of conventional LPS (E. coli, O111:B4, Sigma). Cells were harvested at 6h after stimulation for RNA extraction. At 24h, cell-free supernatants were harvested for cytokine determination by specific ELISA.
Free full text: Click here